These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

307 related articles for article (PubMed ID: 28026830)

  • 21. Nitric oxide regulation of gene transcription via soluble guanylate cyclase and type I cGMP-dependent protein kinase.
    Idriss SD; Gudi T; Casteel DE; Kharitonov VG; Pilz RB; Boss GR
    J Biol Chem; 1999 Apr; 274(14):9489-93. PubMed ID: 10092632
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Modulation of cGMP in heart failure: a new therapeutic paradigm.
    Boerrigter G; Lapp H; Burnett JC
    Handb Exp Pharmacol; 2009; (191):485-506. PubMed ID: 19089342
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Elevated guanylate cyclase and cyclic-guanosine monophosphate-dependent protein kinase levels in nasal mucosae of antigen-challenged rats.
    Sakai H; Hara T; Todoroki K; Igarashi Y; Misawa M; Narita M; Chiba Y
    Microvasc Res; 2013 Nov; 90():150-3. PubMed ID: 24012634
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Nitric-oxide-dependent activation of pig oocytes: the role of the cGMP-signalling pathway.
    Petr J; Rajmon R; Chmelíková E; Tománek M; Lánská V; Pribánová M; Jílek F
    Zygote; 2006 Feb; 14(1):9-16. PubMed ID: 16700970
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Measurement of cGMP and soluble guanylyl cyclase activity.
    Southam E
    Curr Protoc Toxicol; 2001 May; Chapter 10():Unit 10.5. PubMed ID: 23045027
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A cell-based nitric oxide reporter assay useful for the identification and characterization of modulators of the nitric oxide/guanosine 3',5'-cyclic monophosphate pathway.
    Wunder F; Buehler G; Hüser J; Mundt S; Bechem M; Kalthof B
    Anal Biochem; 2007 Apr; 363(2):219-27. PubMed ID: 17336915
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Nitric oxide and cyclic guanosine monophosphate signaling in the eye.
    Murad F
    Can J Ophthalmol; 2008 Jun; 43(3):291-4. PubMed ID: 18443613
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Signal transduction: activation of the guanylate cyclase-cyclic guanosine-3'-5' monophosphate system by hormones and free radicals.
    Vesely DL
    Am J Med Sci; 1997 Nov; 314(5):311-23. PubMed ID: 9365333
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Expression and activity of soluble guanylate cyclase in injury and repair of anti-thy1 glomerulonephritis.
    Peters H; Wang Y; Loof T; Martini S; Kron S; Krämer S; Neumayer HH
    Kidney Int; 2004 Dec; 66(6):2224-36. PubMed ID: 15569311
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Endurance training upregulates the nitric oxide/soluble guanylyl cyclase/cyclic guanosine 3',5'-monophosphate pathway in the striatum, midbrain and cerebellum of male rats.
    Chalimoniuk M; Chrapusta SJ; Lukačova N; Langfort J
    Brain Res; 2015 Aug; 1618():29-40. PubMed ID: 26006108
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The NO/cGMP/PKG pathway in platelets: The therapeutic potential of PDE5 inhibitors in platelet disorders.
    Degjoni A; Campolo F; Stefanini L; Venneri MA
    J Thromb Haemost; 2022 Nov; 20(11):2465-2474. PubMed ID: 35950928
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Role of the nitric oxide-soluble guanylyl cyclase pathway in obstructive airway diseases.
    Dupont LL; Glynos C; Bracke KR; Brouckaert P; Brusselle GG
    Pulm Pharmacol Ther; 2014 Oct; 29(1):1-6. PubMed ID: 25043200
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Receptor-controlled phosphorylation of alpha 1 soluble guanylyl cyclase enhances nitric oxide-dependent cyclic guanosine 5'-monophosphate production in pituitary cells.
    Kostic TS; Andric SA; Stojilkovic SS
    Mol Endocrinol; 2004 Feb; 18(2):458-70. PubMed ID: 14630997
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Stimulation of soluble guanylate cyclase slows progression in anti-thy1-induced chronic glomerulosclerosis.
    Wang Y; Krämer S; Loof T; Martini S; Kron S; Kawachi H; Shimizu F; Neumayer HH; Peters H
    Kidney Int; 2005 Jul; 68(1):47-61. PubMed ID: 15954895
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Nitric oxide-mediated regulation of connexin43 expression and gap junctional intercellular communication in mesangial cells.
    Yao J; Hiramatsu N; Zhu Y; Morioka T; Takeda M; Oite T; Kitamura M
    J Am Soc Nephrol; 2005 Jan; 16(1):58-67. PubMed ID: 15537869
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The alpha2beta1 isoform of guanylyl cyclase mediates plasma membrane localized nitric oxide signalling.
    Bellingham M; Evans TJ
    Cell Signal; 2007 Oct; 19(10):2183-93. PubMed ID: 17643962
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A cell-based cGMP assay useful for ultra-high-throughput screening and identification of modulators of the nitric oxide/cGMP pathway.
    Wunder F; Stasch JP; Hütter J; Alonso-Alija C; Hüser J; Lohrmann E
    Anal Biochem; 2005 Apr; 339(1):104-12. PubMed ID: 15766716
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Human soluble guanylate cyclase as a nitric oxide sensor for NO-signalling reveals a novel function of nitrite reductase.
    Pan J; Xu Q; Lin YW; Zhong F; Tan X
    Chem Commun (Camb); 2013 Aug; 49(67):7454-6. PubMed ID: 23864033
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Sequential activation of soluble guanylate cyclase, protein kinase G and cGMP-degrading phosphodiesterase is necessary for proper induction of long-term potentiation in CA1 of hippocampus. Alterations in hyperammonemia.
    Monfort P; Muñoz MD; Kosenko E; Llansola M; Sánchez-Pérez A; Cauli O; Felipo V
    Neurochem Int; 2004 Nov; 45(6):895-901. PubMed ID: 15312984
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The cGMP system: components and function.
    Hofmann F
    Biol Chem; 2020 Mar; 401(4):447-469. PubMed ID: 31747372
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.